Obese Patients With or Without Comorbidities (RIO-North America)

Phase 3

Completed

• Conditions: Obesity; Weight Loss

• Registration Number: NCT00029861
• Lead Sponsor: Sanofi

Brief Summary

To assess the effects of weight loss and weight maintenance over a period of two years when prescribed with a hypocaloric diet in obese patients with or without comorbidities

Detailed Description

Not available

Study Timeline

• Study Start: 2001-08
• Study First Submitted: 2002-01-23
• Study First Submitted QC: 2002-01-23
• Study First Posted: 2002-01-24
• Primary Completion: 2004-04
• Study Completion: 2004-04
• Status Verified: 2009-04
• Last Update Submitted: 2009-04-17
• Last Update Posted: 2009-04-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3045

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in body weight

Secondary Outcome Measures

Name	Time	Method
Metabolic parameters

Trial Locations

Locations (45)

Radiant Research; 🇺🇸 Austin, Texas, United States

East Bay Clinical Trial Center; 🇺🇸 Concord, California, United States

Feighner Research Institute; 🇺🇸 San Diego, California, United States

Scripps Clinic; 🇺🇸 San Diego, California, United States

Diablo Clinical Research, Inc.; 🇺🇸 Walnut Creek, California, United States

Ranch View Family Medicine; 🇺🇸 Highlands Ranch, Colorado, United States

Longmont Medical Research Network; 🇺🇸 Longmont, Colorado, United States

Health Core, Inc.; 🇺🇸 Newark, Delaware, United States

George Washington Univ. Wieght Mmgt Program; 🇺🇸 Washington, District of Columbia, United States

Miami Research Associates; 🇺🇸 Miami, Florida, United States

Scroll for more (35 remaining)